- Bucharest: KEI Europe Hosts Side Event on Access to Affordable HCV Medicines Saturday 30 May 10:00
- WHA68 KEI side event: Andrew Goldman speaking on compulsory licensing of HCV drug patents
- Put the patents at risk, not the patients
- WHA68: Statement of HAI/KEI on Follow-up to 2014 HLM on comprehensive review + assessment of prevention and control of NCDs
- May 21, 2015- Agenda for KEI/KEI Europe panel on Compulsory licensing of patents on drugs, vaccines and diagnostic tests
- WHA68: Greek Minister of Health - Panagiotis Kouroumplis - calls for de-linkage of R&D from the price of health technologies
- KEI TPP Briefing note 2015:1 Compulsory licenses on patents and the 3-step test
- Letter from Senator Bernie Sanders to the VA, asking for compulsory licenses on Hepatitis C drugs.
- UACT Comments to DHHS on WHA: Agenda Item 13.4 Assessment of Progress in Prevention & Control of NCDs
- KEI Comments to DHHS on WHA Agenda 17.5 (Global Strategy and Plan of Action on Public Health, Innovation and IP)
WTO TRIPS Council (February 2015): EU mounts defense of tobacco plain packing measures in the Republic of Ireland and the UKSubmitted by thiru on 27. February 2015 - 4:56
The following statement was delivered by the European Union on Tuesday, 24 February 2015 at the WTO TRIPS Council during discussions on "Concerns with respect to proposals for plain packaging of tobacco products in the United Kingdom and Ireland".
On Wednesday February 24, 2015, the United States Trade Representative (USTR) Special 301 Committee held its annual public meeting following written comments sent earlier by trade associations, corporations and a few public interest groups that follow trade and intellectual property.
On February 24, 2015, the USTR convened the Special 301 Review, taking testimony almost exclusively from witnesses representing large corporate rights holders. Over the course of the three-and-a-half hour hearing, groups such as Phrma, NAM, IPO, and the misleadingly-named Alliance for Fair Trade with India (an alliance comprised of groups such as Phrma, NAM, MPAA and many other similar groups) as well as foreign-owned multinational Bridgestone, pushed for the watch-listing of countries that fail to implement TRIPS+ measures.
WTO TRIPS Council (February 2015): Bangladesh statement (on behalf of LDC Group)- Extension of the 2016 transitional periodSubmitted by thiru on 25. February 2015 - 5:58
On Tuesday, 24 February 2015, Bangladesh, on behalf of the LDC Group, presented the submission of the LDC Group on an Extension of the Transitional Period Under Article 66.1 of the TRIPS Agreement for LDC Members for Certain Obligations with Respect to Pharmaceutical Products in the following impassioned statement.
ANY OTHER BUSINESS
EXTENSION OF THE TRANSITION PERIOD UNDER ARTICLE 66.1 OF THE TRIPS AGREEMENT FOR LEAST-DEVELOPED COUNTRY MEMBERS FOR CERTAIN OBLIGATIONS WITH RESPECT TO PHARMACEUTICAL PRODUCTS
On Tuesday, 24 February 2015, Bangladesh, on behalf of the LDC Group delivered the following statement on non-violation and situation complaints.
AGENDA 6: NON-VIOLATION AND SITUATION COMPLAINTS
I am taking floor on behalf of the LDC group.
LDCs are concerned that non-violation and situation complaints may pose unnecessary problems to LDCs which can be otherwise avoidable if we do not implement this provision under TRIPS.
WTO TRIPS Council (February 2015): LDC request for extension of the transitional period for pharmaceutical productsSubmitted by thiru on 24. February 2015 - 5:58
The World Trade Organization (WTO) is convening the TRIPS Council from Tuesday, 24 February 2015 to Wednesday, 25 February 2015. As mentioned in a previous piece, Norway and the United States "have submitted a written request for the inclusion of the topic, "Intellectual Property and Innovation: Women And Innovation" (Source: WTO TRIPS Council-February 2015- Norway and the United States bring gender mainstreaming to the fore-Women and Innovation, http://keionline.org/node/2167).
WTO Trade Policy Review of the United States: USTR deflects questions from India on compulsory licensing (December 2014)Submitted by thiru on 21. February 2015 - 0:52
On 16 December 2014 and 18 December 2014, the World Trade Organization (WTO) undertook a trade policy review of the United States of America. All members of the WTO are subject to review under the Trade Policy Review Mechanism (TPRM).
20 February 2015
In accordance with Human Rights Council resolution A/HRC/RES/26/28, the Human Rights Council convened the 2015 Social Forum at the United Nations Palais des Nations in Geneva from 18-20, February 2015 with a focus on "access to medicines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, including best practices in this regard."
Save the Date- 19 February 2015- Fire in the Blood- Screening co-sponsored by KEI/MSF-Access CampaignSubmitted by thiru on 15. February 2015 - 17:19
The Human Rights Council's 2015 Social Forum will take place from 18 February 2015 to 20 February 2015 at the Palais des Nations in Geneva, Switzerland.
As requested by the Council in the above-mentioned resolution, the 2015 Social Forum will focus on "access to medicines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, including best practices in this regard ". (Source: http://www.ohchr.org/EN/Issues/Poverty/SForum/Pages/SForum2015.aspx).
16-18 February 2015 WIPO Expert Forum on International Technology Transfer to examine Alternatives to the Patent SystemSubmitted by thiru on 10. February 2015 - 8:59
The World Intellectual Property Organization (WIPO) will host an Expert Forum on International Technology Transfer on 16 February 2015 to 18 February 2015 at its New Conference Hall. The event is open to the public, and the link for online registration can be found here: http://www.wipo.int/meetings/en/registration/form.jsp?meeting_id=35562.
Attached is a leaked version of Japan's October 3, 2014 proposals for intellectual property for the Regional Comprehensive Economic Partnership.
The Regional Comprehensive Economic Partnership (RCEP) is a proposed free trade agreement (FTA) between the ten member states of the Association of Southeast Asian Nations (ASEAN) (Brunei, Burma (Myanmar), Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam) and the six states with which ASEAN has existing FTAs (Australia, China, India, Japan, South Korea and New Zealand).
Attached are KEI's February 6 comments to USTR on the 2015 Special 301.
Our 7 page submission begins with this:
Attached are KEI's January 30, 2015 comments on the India IP Policy.
This is how the comments begin:
Knowledge Ecology International (KEI) has reviewed the document entitled “National IPR Policy” prepared by the IPR Think Tank. The document is surprisingly lacking in several key areas. In particular:
Today, on World Cancer Day, there has been many great announcements and celebrations.
The FDA approved Pfizer's new drug Ibrance (INN: palbociclib) for the treatment of metastatic (advanced) breast cancer to be used in combination with letrozole based on a 165 person trial at UCLA's cancer center. (FDA press release here, ABC story here.)
WTO TRIPS Council (February 2015): Norway and the United States bring gender mainstreaming to the fore-Women and InnovationSubmitted by thiru on 4. February 2015 - 4:45
The first session of the 2015 World Trade Organization's TRIPS Council takes place from 24 February 2015 to 25 February 2015. Like clockwork, the United States has tabled the inclusion of an additional item on Intellectual Property and Innovation. This marks the 8th time since November 2012 that the United States has submitted the inclusion of an additional agenda item to the TRIPS Council relating to intellectual property or innovation.